TWD 49.15
(-19.82%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 5.27 Million TWD | 94.18% |
2022 | 2.71 Million TWD | 50.64% |
2021 | 1.8 Million TWD | -63.73% |
2020 | 4.97 Million TWD | -37.27% |
2019 | 7.92 Million TWD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 16.5 Million TWD | 1304.72% |
2024 Q2 | 16.5 Million TWD | 0.0% |
2023 Q4 | 1.17 Million TWD | 0.0% |
2023 Q3 | 1.17 Million TWD | -19.63% |
2023 FY | 5.27 Million TWD | 94.18% |
2023 Q1 | 1.46 Million TWD | 157.17% |
2023 Q2 | 1.46 Million TWD | 0.0% |
2022 FY | 2.71 Million TWD | 50.64% |
2022 Q3 | 568.5 Thousand TWD | 0.0% |
2022 Q4 | 568.5 Thousand TWD | 0.0% |
2021 FY | 1.8 Million TWD | -63.73% |
2020 FY | 4.97 Million TWD | -37.27% |
2019 FY | 7.92 Million TWD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -1503.04% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 402.54 Million TWD | 98.69% |
Level Biotechnology Inc. | 219.54 Million TWD | 97.598% |
Sagittarius Life Science Corp | 71.47 Million TWD | 92.621% |
NeoCore Technology Co., Ltd. | -9.08 Million TWD | 158.052% |
TaiMed Biologics Inc. | 225.23 Million TWD | 97.658% |
GlycoNex Incorporation | 995 Thousand TWD | -430.05% |
VBI | 16.42 Million TWD | 67.887% |
GeneReach Biotechnology Corp. | 27.58 Million TWD | 80.88% |
Taiwan Advance Bio-Pharmaceutical Inc. | 198.45 Million TWD | 97.342% |
SynCore Biotechnology Co.,Ltd | 521 Thousand TWD | -912.284% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 95.602% |
Visgeneer Inc. | 67.48 Million TWD | 92.185% |
Mycenax Biotech Inc. | -375.19 Million TWD | 101.406% |
Sunmax Biotechnology Co., Ltd. | 1.4 Billion TWD | 99.625% |
G&E Herbal Biotechnology Co., Ltd. | 144.58 Million TWD | 96.352% |
Neith Corporation | 18.01 Million TWD | 70.731% |
Medigen Vaccine Biologics Corporation | 230.22 Million TWD | 97.709% |
TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | 76.809% |
Enimmune corporation | -23.37 Million TWD | 122.564% |
TaiRx, Inc. | 2.43 Million TWD | -116.236% |
CHO Pharma, Inc. | -28.27 Million TWD | 118.65% |
EirGenix Inc. | 236.74 Million TWD | 97.772% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 94.946% |
Sunny Pharmtech Inc. | 285.52 Million TWD | 98.153% |
Lin BioScience, Inc. | -17.92 Million TWD | 129.419% |
BioGend Therapeutics Co., Ltd. | 89.61 Million TWD | 94.115% |
Feng Chi Biotech Corp. | 80.72 Million TWD | 93.466% |
Bio Preventive Medicine Corp. | 1.08 Million TWD | -386.981% |
Lukas Biomedical Inc. | 133.89 Million TWD | 96.061% |
RBC Bioscience Corporation | 72.89 Million TWD | 92.765% |
BiOptic Inc. | 152.74 Million TWD | 96.547% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -5760.0% |
Shine-On BioMedical Co.,Ltd. | 6.66 Million TWD | 20.894% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -101.683% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 99.181% |
Advagene Biopharma Co., Ltd. | -12 Million TWD | 143.943% |
NaviFUS Corp. | 11.82 Million TWD | 55.407% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 96.77 Million TWD | 94.55% |
Sinew Pharma Inc. | -28.98 Million TWD | 118.196% |
Andros Pharmaceuticals Co.,Ltd | 313 Thousand TWD | -1584.984% |
Greenyn Biotechnology Co., Ltd | 392.45 Million TWD | 98.656% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | 87.286% |
AP Biosciences Inc | 32.25 Million TWD | 83.648% |
Medigen Biotechnology Corp. | 617.32 Million TWD | 99.146% |
Pharmosa Biopharm Inc. | 314.5 Million TWD | 98.323% |
Intech Biopharm Corporation | -163.99 Million TWD | 103.216% |
Oneness Biotech Co., Ltd. | 32.56 Million TWD | 83.803% |
Eusol Biotech Co.,Ltd. | -4.02 Million TWD | 230.901% |
TWi Biotechnology, Inc. | -9.73 Million TWD | 154.153% |
Ever Supreme Bio Technology Co., Ltd | 484.75 Million TWD | 98.912% |
TCI GENE Inc. | 174.61 Million TWD | 96.98% |
MegaPro Biomedical Co., Ltd | -16.6 Million TWD | 131.769% |
Senhwa Biosciences, Inc. | -10.17 Million TWD | 151.843% |
Taiwan Bio Therapeutics Co., Ltd | 76.35 Million TWD | 93.093% |
NatureWise Biotech & Medicals Corporation | 76.96 Million TWD | 93.147% |
PharmaEngine, Inc. | 718.97 Million TWD | 99.266% |
Savior Lifetec Corporation | 220.94 Million TWD | 97.613% |
TaiGen Biopharmaceuticals Holdings Limited | 111.68 Million TWD | 95.278% |
OBI Pharma, Inc. | -73.49 Million TWD | 107.176% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | 96.202% |
Acepodia, Inc. | 16.59 Million TWD | 68.216% |
Caliway Biopharmaceuticals Co., Ltd. | 27.46 Million TWD | 80.8% |